Similarly, the inhibition of c-Src, through the reduction of neuroinflammation, promotes a neuroprotective effect in Parkinson’s disease and Alzheimer’s disease models (Dhawan and Combs, 2012; Tai et al., 2013). Here, SRC is linked to early-onset autosomal dominant Alzheimer disease.